November 24, 2014 3:21 AM ET

Biotechnology

Company Overview of DGI Resolution, Inc.

Company Overview

DGI Resolution, Inc., a human genetics company, discovers genetic risk factors for diseases ranging from cardiovascular disease to cancer. The company generates and analyzes genetic and medical data of various diseases. DGI Resolution, Inc.was formerly known as deCODE genetics Inc. and changed its name to DGI Resolution, Inc. in January 2010. The company was founded in 1996 and is based in Delaware. As of December 10, 2012, DGI Resolution, Inc. operates as a subsidiary of Amgen Inc.

, DE 

United States

Founded in 1996

331 Employees

Key Executives for DGI Resolution, Inc.

Chairman
Age: 65
Vice President of Statistics
Vice President of Informatics
Age: 48
Vice President of Research
Compensation as of Fiscal Year 2014.

DGI Resolution, Inc. Key Developments

GENALICE and deCODE Genetics Enter into a Partnership for Population Wide Genomic Analysis

GENALICE announced that it is partnering with deCODE Genetics to facilitate the large-scale testing of its unique DNA data processing software solution, GENALICE MAP. After a first successful round of evaluating GENALICE MAP on speed and quality, both parties agreed to extend the evaluation to include up to 10,000 full human genomes. Population wide analysis is crucial if the potential of whole genome sequencing for medical application in patients with complex diseases is to be realized. Data processing at that level represents a major challenge, however, GENALICEs unique ability to process a full human genome on general purpose hardware in a matter of minutes makes population wide sequence variation analysis a reality. deCODE Genetics has one of the worlds larger Biobanks and is generating large amounts of full human genome data with its Illumina HiSeq X Ten Next-Generation Sequencing (NGS) machines. GENALICE will install an XL version of its all-in-one bioinformatics appliance, GENALICE VAULT, which is preloaded with MAP, and can process one full human genome every other minute.

Nextcode Gets License from Decode Genetics

Nextcode Health announced that it has secured a license for sequence-based clinical diagnostic applications using technology developed by Decode genetics. Nextcode will hold a five-year exclusive license to use the genomics platform developed by Decode genetics, including IT infrastructure and data analysis capabilities, for sequence-based clinical diagnostic applications. Nextcode will leverage Decode's Genomic Ordered Relational database infrastructure and sequence analysis systems, and will continue to develop these systems for specific needs associated with clinical research and care. Analysis will be supported by access to Decode's collection of genetic variants paired with clinical data. This technology solution will enable Nextcode's customers to analyze genomics data without investing in a substantial IT infrastructure.

NextCODE Health Secures an Exclusive License for Sequence-Based Clinical Diagnostic Applications Using Technology Developed by deCODE Genetics

NextCODE Health announced that it has secured an exclusive license for sequence-based clinical diagnostic applications using technology developed by deCODE genetics. NextCODE will hold a five-year exclusive license to use the genomics platform developed by deCODE genetics - including IT infrastructure and data analysis capabilities - for sequence-based clinical diagnostic applications. NextCODE will leverage deCODE's Genomic Ordered Relational (GOR) database infrastructure and sequence analysis systems, and will continue to develop these systems for specific needs associated with clinical research and care. Analysis will be supported by access to deCODE's substantial, proprietary knowledge base that includes more than 40 million validated variants.

Similar Private Companies By Industry

Company Name Region
Tobira Therapeutics, Inc. United States
Mytogen, Inc. United States
Pyxis Genomics, Inc. United States
Novactyl, Inc. United States
Newport Laboratories, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DGI Resolution, Inc., please visit www.decode.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.